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Abstract Fear, a reaction to a threatening situation, is a
broadly adaptive feature crucial to the survival and repro-
ductive fitness of individual organisms. By contrast, anxi-
ety is an inappropriate behavioral response often to a
perceived, not real, threat. Functional imaging, biochemi-
cal analysis, and lesion studies with humans have identified
the HPA axis and the amygdala as key neuroanatomical
regions driving both fear and anxiety. Abnormalities in
these biological systems lead to misregulated fear and
anxiety behaviors such as panic attacks and post-traumatic
stress disorders. These behaviors are often treated by
increasing serotonin levels at synapses, suggesting a role
for serotonin signaling in ameliorating both fear and anx-
iety. Interestingly, serotonin signaling is highly conserved
between mammals and invertebrates. We propose that
genetically tractable invertebrate models organisms, such
as Drosophila melanogaster and Caenorhabditis elegans,
are ideally suited to unravel the complexity of the serotonin
signaling pathways. These model systems possess well-
defined neuroanatomies and robust serotonin-mediated
behavior and should reveal insights into how serotonin can
modulate human cognitive functions.
Keywords Serotonin  Fear  Anxiety disorder 
D. melanogaster  C. elegans
Introduction
Organisms develop mechanisms to adapt to their changing
environment (Tinbergen 1963; Seligman 1970; Mayr
1974). They use exquisitely designed sensory systems to
receive environmental cues and respond appropriately,
favoring cues that aid survival and reproduction, while
avoiding those that indicate danger (Hollis 1982; Domjan
2005). These complex and often energetically costly sen-
sory systems (e.g., olfactory, gustatory, visual) are typi-
cally coupled with downstream machinery (e.g., cognitive,
hormonal, motor output) in order to take full advantage of
environmental changes (Ames and Li et al. 1992; Attwell
and Laughlin 2001; Lennie 2003; Niven et al. 2003;
Nawroth et al. 2007; Niven et al. 2007). Perhaps the most
crucial of these functions is the ability to recognize a
threat: an increase in temperature, a poisonous fruit, or the
scent of a predator. Individuals that fail to detect and avoid
threats are likely to experience injury or death; thus, the
machinery governing threat response must be precise
(Plutchik 1980).
Fear and anxiety are complex behaviors that represent
responses to environmental threats. These two behaviors
differ in that fear is a response to a real or clearly identi-
fiable threat and functions to remove the individual from a
harmful situation (Belzung and Philippot 2007). In con-
trast, anxiety is a contrived or exaggerated fear response
(Chaffey et al. 2002) and often proceeds in the absence of a
truly threatening stimulus. This important distinction has
led most psychologists and evolutionary biologists to
regard fear as an appropriate and adaptive response (Bar-
low and Durand 2011), and anxiety as psychologically
unhealthy and often associated with unwarranted physio-
logical stress across multiple organ systems (Kessler et al.
2005).
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In this review, we first briefly summarize the history and
biology of anxiety-related disorders; we then describe how
invertebrates, with their powerful genetic tools and relatively
simple neurocircuitry, can contribute to our understanding of
anxiety-related ailments. Of course, an inherent challenge
with the use of an invertebrate model system to analyze a
human emotional behavior is that organisms such as fruit
flies and nematodes do not possess the full suite of characters
that comprise human emotion (Tulving 2001). Most notably,
invertebrates are missing a sophisticated sense of self-
awareness, termed ‘‘autonoetic consciousness’’. This
heightened sense of self facilitates the full experience of
human behavior by mentally placing an individual in the
past, the future and in possible alternative situations as the
threatening stimulus is processed (Tulving 1987; Gardiner
2001; Lou et al. 2004). There is currently no compelling
evidence that any non-hominids are in possession of this
cognitive ability (Tulving 2001; Cloninger 2009). However,
if an emotional behavior is reduced down to its individual
components, one finds that certain components of the
behavior are accessible in simple model systems. For
example, psychologists largely agree that anxiety is com-
posed of three steps: (1) perception and appraisal of a
threatening stimulus, (2) cognitive and physiological pro-
cessing of the stimulus, and (3) specific behavioral output
(including the fight or flight response) (Arnold 1960; Scherer
1984; Lowe and Ziemke 2011). In the final section of this
review, we describe recent work in the nematode, Caeno-
rhabditis elegans, which lends to a circuit level under-
standing of how a threatening stimulus is sensed, and studies
in the fruit fly, Drosophila melanogaster, which describes
how a behavioral response to a threat (fighting) is generated.
Anxiety: a historical perspective
The Greeks may have been the first civilization to formally
recognize anxiety-related disorders as a medical condition
(Gabriel 1987; Hunt 1988). In 332 BC, Aristotle surmised
that ‘‘vapors’’ emanating from the heart and brain could
induce a ‘‘hysteric’’ or especially nervous condition (Stone
1997). In fact, the word ‘‘panic’’ is derived from the Greek
god, Pan, who elicits irrational fear when aroused from his
sleep (Stone 1997). The earliest recorded attempts to
ameliorate anxiety symptoms used sedatives and electrical
stimulation. In the first century AD, patients suffering from
anxiety were sedated using opium (Shorter 1997). A hun-
dred years later, Claudius Galen, a prominent Roman
physician/philosopher (131–201 AD), applied shocks from
electric eels to remedy anxiety-related ailments with
modest success (Stillings 1975).
Medical advances during the nineteenth century allowed
anatomists to correlate specific lesions in brain-damaged
patients to a cognitive or emotional deficiency, a process
known as functional localization (Kandel et al. 2000). In
1861, Pierre Paul Broca used this technique to correctly
link the capacity to articulate speech with a confined por-
tion of the cortex, the inferior frontal gyrus, now termed
‘‘Broca’s area’’ (Broca 1861). In 1937, James Papez, a
Cornell University anatomist, proposed an influential the-
ory of how emotional behaviors are generated and, most
importantly, identified a neural pathway driving these
behaviors, the Papez circuit (Papez 1995). Papez sug-
gested that emotions are invoked via neural pathways
beginning with sensory information and integrated hypo-
thalamal and cortical stimulation (LeDoux 1996). Sub-
sequent neuroanatomical findings have modified this
circuit; however, the broader concept of integrated neural
pathways underpinning emotional behavior remains intact
(Bear 2006).
HPA axis, amygdala, and serotonin: key players driving
mammalian fear and anxiety behaviors
Our current understanding of the neurobiology of fear and
anxiety centers largely on three interrelated systems: the
amygdala, the HPA (hypothalamic–pituitary–adrenal
gland) axis, and neuromodulators (e.g., serotonin) (Fig. 1).
Each of these systems will be briefly discussed; however,
this review will largely focus on the role of serotonin in
modulating these behaviors.
Information encoding a threatening stimulus enters an
individual’s brain, undergoes context-dependent processing
through a sensory neural circuit, and is eventually relayed
to the hypothalamus (Shi and Davis 2001; Davis 2006).
Once activated, the hypothalamus engages the HPA axis: a
hormonal feedback system between two brain regions
(hypothalamus and pituitary) and the adrenal gland (a small
organ on the top of the kidneys) (Fig. 1b). The HPA axis
regulates the bodily reaction to stress and constitutes an
important facet of fearful or anxious behavior (Jacobson
2005). The neurochemical component of fearful/anxious
HPA signaling begins when stressful stimuli prompt the
hypothalamus to release the neuropeptide CRF (corticotro-
phin-releasing factor). CRF release triggers the proximally
located pituitary to release ACTH (adrenocorticotrophin-
releasing hormone) into the bloodstream (Jacobson 2005).
The adrenal cortex detects the increase of ACTH in the
bloodstream and, in turn, triggers the adrenal gland to release
glucocorticoids, including cortisol. A negative feedback
loop is completed when glucocorticoids bind the glucocor-
ticoid receptors on the hypothalamus and pituitary, thereby
suppressing further release of CRF and ACTH (Mathew et al.
2008). Abnormalities in these neurochemical HPA interac-
tions are implicated in multiple stress-related disorders,
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including anxiety (Laue et al. 1991; Licinio et al. 1996; De
Kloet et al. 1998; Pascual 2003).
The amygdala, an almond shaped cluster of nuclei
within the medial temporal lobes of complex vertebrate
brains, is also critical for generating emotional fear and
anxiety behaviors (Kandel et al. 2000; Phelps and LeDoux
2005). The amygdala receives inputs from the sensory
systems (e.g., auditory, visual) via the thalamus and inte-
grates these stimuli with cortical processing (context,
memory, and conscious self-regulation) before generating
efferent signals that contribute to the threat response
(Fig. 1c) (Gray 1999; Phelps and LeDoux 2005; Shin et al.
2006; Hariri and Whalen 2011; Johansen et al. 2011).
Correlative experiments linking functional imaging in the
brain with fear conditioning emphasize the key role played
by the amygdala in fear and anxiety behaviors. Fear con-
ditioning, or Pavlovian fear conditioning, is a form of
learning in which a neutral stimulus (conditioned stimulus)
elicits fearful or anxious behavior after association with an
aversive event (unconditioned stimulus) (Pavlov 1927).
LeDoux and others surmise these two stimuli (conditioned
and unconditioned) are integrated within the amygdala
circuitry via synaptic plasticity and the Hebbian processes
(Johansen et al. 2011).
To date, pharmaceutical attempts to treat anxiety dis-
orders by modulating neurotransmitter activity have had
mixed success. In 1904, Bayer introduced ‘‘Veronal’’, a
barbiturate that soon became the drug of choice in private
nervous clinics (Shorter 1997). Barbiturates act mostly by
enhancing GABA signaling by binding GABA receptors on
target neurons (Nemeroff 2003). Despite its addictive side
effect, Veronal’s initial success led to the development of
chemically similar anxiolytics (anxiety-reducing com-
pounds). Throughout the past century, chemists have pro-
duced various classes of anxiolytics (e.g., beta-blockers,
tricyclic anti-depressants, benzodiazepines) in an attempt
to improve efficacy while minimizing detrimental side
effects (Barlow and Durand 2011). A recent meta-analysis
Fig. 1 Neurobiology of mammalian fear/anxiety response. a Threat-
ening stimulus approaches the subject. A fearful reaction occurs in
response to a definite threat: a real attacker wielding a knife. An
anxious response occurs in response to an imprecise or unknown
threat: a dark shadow reminiscent of an attacker (Kaplan et al. 1998;
Barlow 2002). b Physiological processing of threatening stimulus.
Distressing visual information enters the retina, is processed by visual
circuitry, and activates the hypothalamus (Shi and Davis 2001; Davis
2006). Once engaged, the hypothalamus initiates the HPA axis by
releasing CRF (corticotrophin-releasing factor). In response, the
pituitary releases ACTH (adrenocorticotrophin-releasing hormone)
into the bloodstream, which prompts the adrenal gland to release
glucocorticoids (ex. cortisol). The glucocorticoids bind receptors on
the hypothalamus and pituitary, preventing further release of CRF and
ACTH (Mathew et al. 2008). c Enlarged view of neurological
processing of threatening stimulus. Amygdala processing (purple
arrows): Visual data captured by the retina is first processed by the
thalamus, which in turn innervates the amygdala (green regions). The
amygdala integrates memory information from the hippocampus and
context and autonoetic consciousness from the cortex (LeDoux 2000;
Zald 2003; Phelps and LeDoux 2005) (e.g., orbitofrontal cortex,
anterior cingulate cortex). Additionally, the amygdala reciprocally
innervates various brain regions including locus coeruleus, BNST
(bed nucleus of the stria terminalis), anterior insula, and hypothal-
amus (Paulus and Stein 2006; Mathew et al. 2008) (regions not
shown). Serotonergic circuit (red arrows): Serotonin is released from
pre-synaptic neurons within the dorsal and median raphe nuclei on the
midline of the brainstem. Serotonergic neurons innervate regions of
the cerebellum, thalamus, hippocampus, hypothalamus, basal ganglia,
frontal cortex, and amygdala (Kandel et al. 2000)
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of multiple classes of drug treatments for general anxiety
disorder determined that fluoxetine (Prozac), a selective
serotonin reuptake inhibitor (SSRI), elicits the highest
patient response to treatment (Baldwin et al. 2011). SSRIs
block the reuptake of serotonin into the presynaptic nerve
terminals, thereby increasing the synaptic concentration of
serotonin (Fig. 2a) (Kandel et al. 2000). Of patients suf-
fering from anxiety, 63 % report amelioration of symptoms
when treated with Prozac (Baldwin et al. 2011). This high
efficacy has made Prozac the primary, first-line treatment
for anxiety disorders (Koen and Stein 2011).
The serotonin pathway
The high success rate of SSRIs strongly suggests a bio-
logical link between anxiety and the serotonin pathway;
however, the details of this link remain unclear. Serotonin
(5HT), a monoamine neurotransmitter, is utilized by most
of the animal kingdom as a neural circuit modulator (Hen
1993). In mammals, serotonin modulates a wide range of
behaviors, including pain perception, sleep, aggression,
feeding, and mood (Hen 1993; Weiger 1997; Carre-Pierrat
et al. 2006). Serotonergic neurons originate from the dorsal
and median raphe nuclei in the brain stem and project into
multiple forebrain and limbic structures (e.g., amygdala,
thalamus, hypothalamus, hippocampus, and frontal cortex),
thereby constituting a serotonin circuit (Fig. 1c) (Kandel
et al. 2000). Fear and anxiety stimuli selectively activate
serotonergic neurons in the dorsal raphe nucleus, which
then project into the amygdala and the hypothalamic por-
tion of the HPA axis (Goddard and Charney 1997; Lowry
2002; Bauman and Amaral 2005; Spannuth et al. 2011).
One model to explain SSRI efficacy reasons that serotonin
can suppress the hyperactivation of the amygdala (Harmer
et al. 2006; Furmark 2009). While SSRIs might have
multiple neural circuit targets, their treatment successes
emphasize a crucial role for serotonin in modulating human
anxiety-related behavior.
The molecular machinery governing serotonin signaling
across neurons is well characterized and also well con-
served among vertebrates and invertebrates (Fig. 2).
Serotonin is synthesized from tryptophan by tryptophan
hydroxylase in the cytoplasm of the presynaptic seroto-
nergic neuron. Vesicle monoamine transporters then
package serotonin into vesicles. These vesicles fuse with
the cell membrane and the stored neurotransmitter is
released into the synaptic cleft and bound by serotonin
receptors on the surface of postsynaptic cells. The signal is
terminated when unbound serotonin is reabsorbed back into
the presynaptic cell by reuptake transporters, thereby
limiting the spread of 5HT concentration. Finally, a cata-
bolic enzyme, monoamine oxidase, metabolizes 5HT to
non-active aldehyde derivatives (Horvitz et al. 1982;
Kandel et al. 2000; Chase and Koelle 2007). Discrepancies
in the activity of the serotonin pathway correlate with
anxious behaviors. Combining functional imaging with
genomic analysis, researchers have associated a short allele
of the promoter (5-HTTLPR) for the human serotonin
transporter gene (SLC6A4) with anxiety-related personality
traits, for example, fear condition-ability (Hariri et al. 2002).
Individuals carrying one or two copies of the truncated
version of SLC6A4 exhibit reduced serotonin signaling and,
interestingly, greater amygdala activity. Consistent with
these findings, high-anxiety subjects carrying the short allele
of the serotonin transporter promoter, 5-HTTLPR, exhibit
elevated amygdala activity during an anxiety-inducing
public speaking task compared to carriers of the long allele
(Furmark et al. 2004). These studies suggest 5HT can sup-
press the activity in the amygdala that is relevant to anxiety.
Serotonin complexity hinders precise understanding
While these studies implicate a strong link between sero-
tonergic circuits and fear and anxiety behavior, less is
known about how serotonin modulates neural circuits to
affect these behaviors (Baldwin et al. 2011; Koen and Stein
2011). Treatments that deplete serotonin levels have pro-
duced both anxiety-reducing and anxiety-inducing behav-
ior (Handley 1995). This paradox is further illustrated by
the fact that long-term exposure to SSRIs reduces anxiety,
while acute exposure (first 2 weeks of treatment) is often
accompanied with anxiety-inducing behavior in both
humans and animal models (Gordon and Hen 2004; Grillon
et al. 2007). Furthermore, it should be noted that the sig-
nificance of SSRI efficacy, in regard to its antidepressant
benefits, is currently being debated. Irving Kirsch and
colleagues performed a meta-analysis of published and
unpublished data (obtained from the FDA via the Freedom
of Information Act) analyzing 35 placebo-controlled trials
of four popular SSRI drugs (Fluoxetine, Venlafaxine, Ne-
fazodone, Paroxetine). The study concluded that, compared
with placebo, these new-generation SSRI antidepressants
do not produce clinically significant improvements in
patients with mild or moderate depression, but do show
significant effects only in severely depressed patients
(Kirsch et al. 2008; Horder et al. 2011). It remains unclear
what biological variation generates this multitude of
behavioral responses to pharmacological intervention.
Taken together, these SSRI-related incongruities empha-
size our incomplete understanding of the complexities of
serotonin signaling as it pertains to cognitive behaviors.
While functional imaging and genetic analysis of humans
have provided a neuroanatomical map of serotonin-modu-
lated behaviors, attempts to elucidate a circuit level
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understanding of anxious behavior have only been margin-
ally successful due to the cellular complexity of the mam-
malian brain. This is understandable; the human brain
consists of approximately 100 billion interconnected neu-
rons, which are largely inaccessible for analysis (Kandel
et al. 2000). Fortunately, the serotonin machinery is largely
conserved throughout the animal kingdom (Fig. 2), facili-
tating the study of this intricate pathway in biological systems
that are more tractable than the mammalian brain. Ideally,
such a model should be capable of executing sophisticated
behaviors that are modulated by serotonin signaling. Small
invertebrate model systems such as D. melanogaster and
C. elegans are exceptionally suited to this task (Kaletta and
Hengartner 2006; Iliadi 2009; Pungaliya et al. 2009;
Dimitriadi and Hart 2010; Kullyev et al. 2010).
Serotonin signaling in C. elegans aversive behavior
The nematode, C. elegans, with just 302 neurons connected
by identified chemical and electrical synapses (White et al.
1986) is ideally suited to unravel conserved serotonin
signaling pathways driving whole animal behavior. In
the worm, serotonin is made from 6 neuronal types
Fig. 2 Conservation of serotonin pathway machinery. a Mammalian
serotonin pathway. TPH Tryptophan hydroxylase synthesizes Sero-
tonin (5-HT) from tryptophan. There are 2 mammalian TPH isoforms:
TPH-1 and TPH-2 (Walther al. 2003). The VMAT vesicular mono-
amine transporter pumps 5-HT from the cytoplasm into either small
synaptic vesicles or dense core vesicles (Liu and Edwards 1997).
There are 2 mammalian VMAT proteins: VMAT1, found in
neuroendocrine cells, and VMAT2, expressed in all CNS serotonergic
neurons (Erickson et al. 1992; Weihe et al. 1994). Post-synaptic
neurons express 7 classes of serotonin receptors. 5-HT1, 5-HT2,
5-HT4, 5-HT5, 5-HT6, 5-HT7 are GPCR G-protein-couple receptors
(Hartig 1997). 5-HT3 is a ligand-gated sodium channel with no
orthologue in the invertebrates (Hanna et al. 2000). SERT Serotonin
transporter protein removes 5-HT from the synaptic cleft (Chang et al.
1996). 5-HT is degraded by MAO monoamine oxidase, which
catalyzes oxidative deamination of 5-HT. There are 2 forms: MAO
A and MAO B (Bach et al. 1988). b D. melanogaster serotonin
pathway. Serotonin (5-HT) is synthesized by 2 tryptophan hydrox-
ylase homologues: DTRHn (hydroxylates tyryptophan) and DTPHu
(hydroxylates both tryptophan and phenylalanine) (Neckameyer and
White 1992; Neckameyer et al. 2007). 5-HT is packaged into vesicles
with DVMAT, homologous to mammalian VMAT1 and VMAT2
(Greer et al. 2005). 4 classes of serotonin receptors have been
identified: 5-HT7Dro is functionally similar to 5HT7 (Becnel et al.
2011). 5-HT1ADro and 5-HT1BDro are most functionally similar to
5HT1 (Gerhardt et al. 1996). 5-HT2Dro is related in structure and
pharmacology to 5-HT2 (Colas et al. 1995). 5-HT is removed from
the synaptic cleft by DSERT, homologous to mammalian SERT
(Demchyshyn et al. 1994). c C. elegans serotonin pathway. Serotonin
(5-HT) is synthesized by TPH-1 (Sze et al. 2000). 5-HT is packaged
with VMAT, homologous to mammalian VMAT1 and VMAT2
(Duerr et al. 1999). Five serotonin receptors have been identified in
C. elegans. Four are G-protein coupled receptors (GPCR): SER-4
resembles 5HT1 (Olde and McCombie 1997), SER-5 has only
sequence similarity to 5-HT6 (Hapiak et al. 2009), SER-1, a 5HT2-
like receptor (Hamdan et al. 1999) and SER-7, homologous to 5-HT7
mammalian receptor (Hobson et al. 2003). MOD-1 is a 5-HT gated
chloride channel not found in mammals (Ranganathan et al. 2000).
5-HT is removed from the synaptic cleft by MOD-5, a serotonin
reuptake transporter (Cooper et al. 1996). MOD-5 is homologous to
mammalian SERT (Ranganathan et al. 2001). Once removed from the
cleft, 5HT is degraded by an enzyme homologous to monoamine
oxidase (Weyler 1992)
b
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(HSN, NSM, VC4, VC5, ADF, and CP1-6) by a tryptophan
hydroxylase (TPH-1) with strong homology to mammalian
TPH-1 (Sze and Victor et al. 2000). Similar to mammalian
serotonergic neurons (Fig. 2), a C. elegans VMAT pack-
ages serotonin into vesicles (Duerr et al. 1999). Also,
C. elegans neurons express at least five different serotonin
receptors: SER-4 (5-HT1-like), SER-1 (5-HT2-like), SER-5
(5-HT6-like), SER-7 (5-HT7-like), and MOD-1 (a 5-HT
gated Cl- channel not found in mammals) (Olde and
McCombie 1997; Hamdan et al. 1999; Ranganathan et al.
2000; Hobson et al. 2003; Hapiak et al. 2009). Moreover,
MOD-5, the worm homologue of mammalian SERT, acts
to remove serotonin from synapses (Ranganathan et al.
2001). Interestingly, fluoxetine, a commonly used SSRI
that blocks mammalian SERT, can also block MOD-5
(C. elegans SERT homologue), among other targets in the
worm (Kullyev et al. 2010).
In C. elegans, serotonin signaling plays a significant role
in mediating avoidance to the repellent odorant, octanol
(Segalat et al. 1995; Troemel et al. 1997; Sawin et al.
2000). As previously mentioned, the perception and
appraisal of a stressful or repellent stimulus is the first
component of anxious or fearful behavior in humans.
Before an organism can determine an appropriate behav-
ioral output, the threatening stimulus must be accurately
processed via the sensory system. As described below,
elegant studies in C. elegans, which seek to unravel the
mechanisms of avoidance behavior, provide insights into
serotonin-mediated sensory activity. The studies reveal
specific interactions of different serotonin receptors acting
in concert with peptidergic and additional monoaminergic
pathways (Chao et al. 2004; Harris et al. 2009, 2010; Mills
et al. 2012).
The Komunieki laboratory has utilized sensory-medi-
ated avoidance behavior, driven by a well-defined neuronal
circuit, to dissect the pathways governing serotonin-medi-
ated stimulus appraisal (Chalfie et al. 1985; Chao et al.
2004; Hilliard et al. 2004). The group has identified cell-
specific roles for serotonin receptors facilitating avoidance
to 30 % octanol, a C. elegans repellent. To administer the
repellent, a hair is taped to a toothpick, dipped in 30 %
octanol, and placed in front of a worm exhibiting forward
sinusoidal locomotion (Harris et al. 2009). Using mutant
analysis and cell-specific RNAi knockdown, Harris and
colleagues determined that MOD-1, the serotonin gated
Cl- channel, is necessary in the AIB interneuron to properly
receive sensory input and that SER-1, the G-protein-cou-
pled serotonin receptor, is required in the RIA/ring motor
neuron to properly innervate head muscle. Upon deter-
mining the repellent was sensed by the ASH amphid sen-
sory neuron but not finding a known serotonin receptor in
ASH, the group performed an RNAi knockdown of
previously uncharacterized C. elegans biogenic amine
receptors and identified SER-5 to be essential for the
serotonergic modulation of aversive responses to 30 %
octanol (Harris et al. 2009). SER-5 is a novel serotonin
receptor that, based on sequence similarity and conserved
functional motifs, is most closely related to mammalian
5-HT6 receptors. Together, these findings identify multiple
points within a neurological circuit from which serotonin
can exert control on the response to an aversive agent.
Additional reports from this group have described how
peptide signaling and octopamine signaling integrate with
this serotonin circuit to provide a dynamic system for
modulating sensory-mediated locomotion (Harris et al.
2010). Harris and colleagues found octopamine signaling
inhibits the serotonin sensitized ASH neuron from initiat-
ing aversive behavior. Octopamine is an invertebrate bio-
genic amine that is, structurally, closely related to
norepinephrine (Roeder et al. 2003). The group found that
octopamine exerts this negative control in the ASH neuron
via three alpha-adrenergic-like octopamine receptors:
OCTR-1, SER-3, and SER-6 (Mills et al. 2012). Interest-
ingly, this group also identified a peptidergic pathway that
exerts a positive effect on ASH activity. Cell-specific
RNAi knockdown determined that C. elegans aversive
response requires a suite of peptides encoded by the neu-
ropeptide, nlp-3. nlp-3 signals via the receptor NPR-17 and
acts in coordination with a suite of G alpha genes that
overlap with octopamine signaling (Harris et al. 2010). To
summarize, these studies describe in impressive detail the
manner that a sensory circuit is modulated by multiple
monoaminergic and peptidergic signaling pathways. Their
findings provide many candidate genes and interactions to
explore for mammalian avoidance behavior.
Serotonin signaling in D. melanogaster aggression
One of the key elements of fear/anxiety behavior in the
vertebrate is the ability to appropriately respond to an
external threat. One aspect of a threat response, aggression,
particularly in the context of a threat from a con-specific,
has been modeled in a simple invertebrate, Drosophila. Not
surprisingly, serotonin plays an integral role in modulating
this behavior.
The fly brain is composed of multiple cell clusters, many
of which include varicosities containing serotonin. A
complete account of serotonin positive neurons was first
mapped in Drosophila (Valles and White 1988) using
immunocytochemical techniques that were originally used
to identify serotonin circuits in non-Drosophila insects
(e.g., grasshoppers, cockroaches) (Bishop and O’Shea
1983; Nassel and Klemm 1983; Taghert and Goodman
1984). Though the numbers of Drosophila serotonin posi-
tive neurons identified represent a small fraction of the total
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neuronal population, their arborization pattern indicates a
crucial role for serotonin. The larval serotonin (5-HT)
pattern consists of 84 neurons distributed in clusters of one
to five neurons labeled SP1, SP2, IP, LP1, LP2, SE1, SE2,
SE3, T1, T2, T3, A1-7, and A8 (Valles and White 1988).
Further, these clusters are arranged across the two brain
hemispheres and the projections fasciculate around the
central commissure and innervate the contralateral brain
hemisphere (Valles and White 1988; Lundell and Hirsh
1994). In the periphery, 5-HT positive neurons project to
the pharynx, proventriculus, the midgut, and the ring gland
(larval endocrine organ). In the adult, two new 5-HT
clusters (LP2A and LP2B) are added and these are located
in the brain near the medulla neuropil. 5-HT is also found
in the ellipsoid body of the central complex, all neuropil
regions of the optic ganglia, the thoracic ganglia, and the
fused abdominal ganglia (Monastirioti 1999). Interestingly,
in Drosophila and likely other animals, 5-HT is found in a
number of neurons that cannot synthesize 5-HT (Valles and
White 1988). This result suggests that serotonin re-uptake
machinery is expressed in non-serotonin producing cells
allowing this key neuromodulator to influence additional
circuits (circuits not identified by 5-HT immunoreactivity).
Similar to the vertebrate (Fig. 2b), serotonin is synthe-
sized by two tryptophan hydroxylases and packaged into
vesicles by DVMAT (Neckameyer and White 1992; Greer
et al. 2005; Neckameyer et al. 2007). Serotonin can
activate four receptor subtypes with distinct expression
patterns and signaling properties. These receptors are
homologous to mammalian receptors in regard to sequence
and downstream activity. 5-HT1ADro and 5-HT1BDro are
homologues of mammalian 5HT1 and are also positively
coupled to adenylate cyclase (Witz et al. 1990; Gerhardt
et al. 1996). 5-HT2Dro is similar to mammalian 5-HT2 and
activates phospholipase C (Saudou et al. 1992; Colas et al.
1995). 5-HT7Dro is functionally similar to vertebrate
5-HT7 and upon activation increases cAMP signaling
(Saudou et al. 1992). Finally, a serotonin transporter,
dSERT, has been identified that has strong sequence and
functional homology to the mammalian SERT. This
transporter functions to remove serotonin from the synaptic
cleft and is highly sensitive to cocaine and anti-depressants
(Corey, Quick et al. 1994; Demchyshyn, Pristupa et al.
1994).
This conserved signaling machinery and powerful
genetics make Drosophila a suitable model to dissect
serotonin-mediated behavior. As mentioned, we focus our
discussion to one such behavior, a fighting response to an
environmental stressor. Drosophila exhibits aggressive
behavior (Jacobs 1978), which is ethologically (Skrzipek
et al. 1979; Lee and Hall 2000) and evolutionarily well
established (Boake and Hoikkala 1995; Boake et al. 1998).
Male flies under appropriate conditions will occupy a food
patch and defend it against other males (Hoffman and
Cacoyianni 1989; Hoffman and Cacoyianni 1990). This
observation has been transformed into a behavioral assay
where pairs of 5- to 7-day-old male flies are placed together
in a small chamber (1.6 cm diameter, 1.1 cm height). A
careful filming of these encounters found unambiguous
offensive fighting elements including wing threat, lunging,
holding, tussling, and boxing (Dierick and Greenspan
2007). Interestingly, serotonin pharmacology has been
found to play an important role in mediating this aggressive
fighting behavior. Flies exposed to 5-HTP, a serotonin
precursor, experience a maximum increase in serotonin
(5-HT) expression 3 days after treatment, while aMTP, an
inhibitor, blocked 5-HT signaling 4 days after exposure.
Elevating 5-HT pharmacologically increases aggression in
flies, while silencing the serotonergic circuits makes the
flies behaviorally unresponsive to the drugs (Dierick and
Greenspan 2007). This study was further extended by
testing the acute modulation of 5-HT neurotransmission
(Alekseyenko et al. 2010). Expression of temperature-
sensitive dTrpA1 channels allowed acute activation of
serotonergic neurons, which caused flies to escalate fights
faster and at higher intensity. In contrast, disruption of
5-HT signaling interferes with the male’s ability to fight
and create a dominance relationship (Alekseyenko et al.
2010).
Behavioral traits, such as aggression, are biologically
complex, and therefore, establishing a connection between
the Drosophila aggression phenotype and its underlying
genotype often necessitates an understanding of how spe-
cific genes orchestrate the development and physiology of
the neural circuits that govern the behavioral action (Siw-
icki and Kravitz 2009). As mentioned above, Drosophila
aggression is a male-specific phenotype, which suggests
aggression is controlled by a sexually dimorphic neural
circuit. Ongoing work from the Kravitz laboratory explores
how genetic interactions in certain neurons specify the
development of these sexually dimorphic neural circuits.
fruitless (fru), a zinc-finger-like transcription factor, is a
part of the sex determination hierarchy of genes in Dro-
sophila that control both morphological and behavioral
sexual dimorphisms (Siwicki and Kravitz 2009). Tran-
scripts of fru undergo complex sex-specific splicing early
in Drosophila development, ultimately yielding a male-
specific fru isoform, FruM, and a female-specific fru
isoform, FruF. The expression of FruM is necessary and
sufficient to specify the neural systems that generate the
male patterns of aggressive behavior (Demir and Dickson
2005; Vrontou et al. 2006). Interestingly, a distinctive
group of large serotonergic neurons at the posterior tip of
the abdominal ganglion (SAbg neurons) express multiple
versions of the FruM isoform (Lee and Hall 2001; Lee et al.
2001). These serotonergic neurons innervate the male
Invert Neurosci (2012) 12:81–92 87
123
reproductive organs. The presence of multiple FruM iso-
forms complicates analysis, but the implication is that
different combinations of fru gene products specify par-
ticular components of the neural circuitry concerned with
sexually dimorphic behaviors; then, once developed, this
circuit can be modulated by serotonergic transmission to
effect aggression (Siwicki and Kravitz 2009).
Of course, further cell-specific experiments are needed
to define serotonin’s contribution to the neural circuits that
drive aggression. We expect the identity of these seroto-
nergic neurons coupled with genetic marking tools (e.g.
MARCM) should reveal additional modulators of the
aggression circuitry, including but not limited to pepti-
dergic or other monoaminergic pathways. Together, these
studies highlight the importance of serotonin signaling and
position D. melanogaster as a model to study the role of
serotonin in cognitive processes relevant to the mammalian
brain.
Conclusions
Human emotional behaviors are generated by a multitude
of biological processes. Many of these processes are con-
tingent on the unique neuroarchitecture of complex human
cognition and physiology. As stated, one could never
accurately model the entire panoply of a human emotional
behavior, like anxiety, in an organism that lacks human-
like emotional and cerebral capacity. However, we specu-
late that it is possible to reduce a human emotional
behavior down to its component parts and analyze the
biological machinery governing individual components
using a simpler genetic model. Of course, this analysis is
only relevant if the biological machinery in question is
conserved between humans and the model organism.
Three interrelated processes help govern human anxiety:
the HPA axis, amygdala processing, and serotonin neuro-
modulation. Neuroanatomical ensembles (HPA axis and
amygdala) are vertebrate specific and, therefore, are not
candidates for analysis using invertebrate model organ-
isms. However, serotonergic transmission is remarkably
well conserved between D. melanogaster, C. elegans, and
H. sapiens (Fig. 2), despite approximately 550 million
years of independent evolutionary trajectories (Valentine
et al. 1999). This conservation allows the possibility of
utilizing nematodes and flies, with their tractable nervous
systems, to explore the specifics of serotonin circuitry as it
relates to complex behavioral outputs.
Serotonin signaling certainly modulates affective dis-
orders (i.e., anxiety) in mammals and, as described, also
modulates aversive behavior and aggression in invertebrate
model organisms. Aversion and aggression do not serve
as complete models of anxiety, but rather represent
components of this complex human behavior. By observing
aversion and aggression in model systems while simulta-
neously perturbing the genetic/cellular components of the
serotonin pathway, one can begin to resolve the complexity
of this neurotransmitter’s actions and its intricate interac-
tions with additional signaling pathways. This level of
analysis is currently unavailable to mammalian systems,
and results from the invertebrate models have the potential
to inform the broader neuroscience community.
Treating anxiety disorders with selective serotonin re-
uptake inhibitors has demonstrated efficacy; However, the
adverse side effects associated with SSRIs and their habit
of acute anxiety-induction suggest that SSRIs have multi-
ple effects on neurological circuits. A circuit level com-
prehension of serotonin neuromodulation will greatly
enhance our ability to understand and treat anxiety-related
disorders. As discussed, serotonin circuits in C. elegans are
controlled at multiple points by cell-specific receptors and
further modulated by octopamine and neuropeptide sig-
naling pathways (Harris et al. 2009, 2010). Perhaps similar
circuit level interactions are governing serotonin signaling
in the mammalian amygdala, as it pertains to anxiety-
related behaviors. The amygdala, specifically the lateral
amygdala, has been identified as a key anatomical brain
region where circuits involved in the processing of
threatening stimulus are housed (LeDoux 2000; Kim and
Jung 2006). In all mammalian species studied, the lateral
amygdala exhibit exceptionally dense serotonergic inner-
vation, largely originating from the dorsal raphe nucleus
(Smith and Porrino 2008; Bonn et al. 2012). It is possible
that particular serotonin receptors acting in specific neu-
rons can modulate the manner conditioned and uncondi-
tioned stimulus are processed (i.e., coupled) within the
serotonergic circuits in the amygdala. Intricate interactions
between peptidergic (e.g., neuropeptide Y) and monoam-
inergic systems (e.g., dopamine, norepinephrine) may
couple with serotonin signaling (via distinct serotonin
receptors) to provide a more dynamic and sophisticated
response to environmental stressors. As circuit level details
emerge from invertebrate model systems, candidate inter-
actions are identified, which can then be explored within
serotonergic circuits of the lateral amygdala in mammalian
systems. We propose that further circuit level analysis of
serotonin-mediated behaviors in invertebrate systems will
increase our comprehension of serotonin-influenced fearful
and anxiety-related behaviors in humans, such as PTSD,
phobias, and panic attacks.
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